Neurofeedback: potential for abuse and regulatory frameworks in the United States.

implicit neurofeedback implicit training law neurofeedback technology regulations undue influence

Journal

Philosophical transactions of the Royal Society of London. Series B, Biological sciences
ISSN: 1471-2970
Titre abrégé: Philos Trans R Soc Lond B Biol Sci
Pays: England
ID NLM: 7503623

Informations de publication

Date de publication:
02 Dec 2024
Historique:
medline: 21 10 2024
pubmed: 21 10 2024
entrez: 21 10 2024
Statut: ppublish

Résumé

Neurofeedback is a brain-training technique that continues to develop via ongoing innovations, and that has broadening potential impact. Once confined primarily to clinical and research settings, it is increasingly being used in the general population. Such development raises concerns about the current regulatory mechanisms and their adequacy in protecting patterns of economic and political decision-making from the novel technology. As studies have found neurofeedback to change subjects' preferences and mental associations covertly, there is a possibility it will be abused for political and commercial gains. Current regulatory practices (including disclaimer requirements, unfair and deceptive trade practice statutes and undue influence law) may be avenues from which to regulate neurofeedback influence. They are, however, limited. Regulating neurofeedback will face the line-drawing problem of determining when it induces an unacceptable level of influence. We suggest experiments that will clarify how the parameters of neurofeedback training affect its level of influence. In addition, we assert that the reactive nature of the traditional models of regulation will be inadequate against this and other rapidly transforming technologies. An integrated and proactive regulatory system designed for flexibility must be adopted to protect society in this era of modern technological advancement. This article is part of the theme issue 'Neurofeedback: new territories and neurocognitive mechanisms of endogenous neuromodulation'.

Identifiants

pubmed: 39428883
doi: 10.1098/rstb.2023.0099
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

20230099

Subventions

Organisme : Yale Law School
Organisme : NIMH NIH HHS
Pays : United States

Auteurs

Fiona Furnari (F)

Yale Law School , New Haven, CT 06511, USA.

Haesoo Park (H)

Department of Radiology and Biomedical Imaging, Yale School of Medicine , New Haven, CT 06510, USA.

Gideon Yaffe (G)

Yale Law School , New Haven, CT 06511, USA.

Michelle Hampson (M)

Department of Radiology and Biomedical Imaging, Yale School of Medicine , New Haven, CT 06510, USA.
Department of Psychiatry, Yale School of Medicine , New Haven, CT 06511, USA.
Department of Biomedical Engineering, Yale School of Engineering and Applied Science , New Haven, CT 06511, USA.
Child Study Center, Yale School of Medicine , New Haven, CT 06520, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH